BridgeMD
New treatment option for Endometriosis
Official title Effect of FODMAP Diet on Pain, Quality of Life, and Sexual Function in Women With Pelvic Endometriosis and Gastrointestinal Symptoms
ClinicalTrials.gov ID: NCT07590895
What this study is testing
- What it's testing
- The main objective of the study is to assess whether a dietary regimen based on the principles of the FODMAP diet, compared with the current treatment programme which does not include specific dietary recommendations, can improve pain symptoms in patients with symptomatic endometriosis and intestinal symptoms (i.e. bloating, nausea, constipation, diarrhoea and vomiting) attributable to irritable bowel syndrome, compared with a control group
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Age between 18 and 45 years
- BMI between 18.5 and 24.9,
- Surgical, clinical or instrumental diagnosis of endometriosis
- Presence of bowel symptoms (i.e., bloating, nausea, constipation, diarrhea, and vomiting) referable to irritable bowel syndrome, on estro-progestin...
You likely can't join if
- Associated conditions that may cause pelvic pain independent of the presence of endometriosis (e.g., pelvic varices and salpingitis outcomes)
- chronic inflammatory bowel disease (Crohn's disease or ulcerative rectocolitis).
- patients with obstructive uropathy, subocclusive intestinal stenosis
- complex adnexal masses or typical endometriomas greater than 5 cm in diameter.
- women who are obese (BMI ≥ 30) or underweight (BMI \< 18)
- women on vegetarian-vegan dietary regimens,
See the full eligibility criteria
- Age between 18 and 45 years
- BMI between 18.5 and 24.9,
- Surgical, clinical or instrumental diagnosis of endometriosis
- Presence of bowel symptoms (i.e., bloating, nausea, constipation, diarrhea, and vomiting) referable to irritable bowel syndrome, on estro-progestin or progestin treatment or in the absence of hormonal treatment
- Associated conditions that may cause pelvic pain independent of the presence of endometriosis (e.g., pelvic varices and salpingitis outcomes)
- chronic inflammatory bowel disease (Crohn's disease or ulcerative rectocolitis).
- patients with obstructive uropathy, subocclusive intestinal stenosis
- complex adnexal masses or typical endometriomas greater than 5 cm in diameter.
- women who are obese (BMI ≥ 30) or underweight (BMI \< 18)
- women on vegetarian-vegan dietary regimens,
- women with metabolic diseases that require specific dietary indications such as in the case of diabetes and celiac disease.
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.